Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Up 50.4% in September

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 4,210,000 shares, a growth of 50.4% from the August 31st total of 2,800,000 shares. Based on an average trading volume of 1,120,000 shares, the short-interest ratio […]

Related Keywords

Stephen Ray Mitchell ,Lazard Asset Management ,Financial Services Group Inc ,Insider Activity At Vanda Pharmaceuticals ,Vanda Pharmaceuticals Inc ,News Ratings For Vanda Pharmaceuticals Daily ,Quadrant Capital Group ,Nasdaq ,Securities Exchange Commission ,Vanda Pharmaceuticals ,Tower Research Capital ,Vanda Pharmaceuticals Trading Down ,Get Free Report ,Pharmaceuticals Trading Down ,Director Stephen Ray Mitchell ,Exchange Commission ,Capital Group ,Research Capital ,Asset Management ,Services Group ,Pharmaceuticals Inc ,Vanda Pharmaceuticals Daily ,Nasdaq Vnda ,Vnda ,Medical ,92165910 ,Stocks ,Options ,Put ,Call ,